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Executive summary
1. A total of 608 very low birth weight infants 
(VLBW) were born in the Republic of Ireland 
(ROI) in 2014, of which two infants were 
<401g but ≥22 wks gestation and 16 infants 
were >1500g but ≤29 wks gestation.
2. In all, 228 infants were born with a birth 
weight ≤1000g and 158 infants were born 
with a gestational age ≤26 wks.
3. National survival figures for VLBW infants 
according to birth weight and gestational 
age categories are reported. 
4. The Standardised Mortality Rate (SMR) for 
VLBW infants born in the ROI was 1.27 (95% 
CI: 1.03, 1.51). The number of observed 
cases of death was 1.27 times the expected 
number: this finding was statistically 
significant.
 5. Excluding early deaths (deaths in the 
Delivery Room or deaths within 12 hours of 
admission to the NICU), the standardised 
mortality rate was 1.23 (95% CI: 0.92, 1.54). 
The number of cases observed did not 
exceed the number of cases expected. 
6.  More VLBW infants in the ROI are born with 
a major congenital malformation than in 
the Vermont Oxford Network (VON) (9% vs 
5%): this finding was statistically significant 
(p<0.001). 
7.  Survival for infants born at 23 weeks 
gestation in 2014 was 19%. More VLBW 
infants born at less than 24 weeks gestation 
in the ROI die in the Delivery Room than 
in VON  (88% in the ROI vs 39% in VON): 
this finding was statistically significant 
(p<0.001). The availability of these data 
will be an invaluable resource to healthcare 
providers who counsel families that are 
about to deliver an infant at the “limits of 
viability”. They help guide clinicians and 
families on decisions regarding transfer to a 
tertiary neonatal centre in anticipation of an 
imminent delivery. 
8. Standardised Morbidity Rates for Key 
Performance Indicators in Neonatal Care of 
VLBW infants suggest that:
	 •	 VLBW	 infants	 born	 in	 the	 ROI	 have	 
 significantly higher rates of 
 pneumothorax. SMR for pneumothorax: 
 1.67 (95% CI: 1.25, 2.10).
	 •	 VLBW	 infants	 born	 in	 the	 ROI	 have	 
 significantly higher rates of coagulase 
 negative staphylococcus infection. SMR 
 for coagulase negative infection: 1.84 
 (95% CI: 1.45, 2.23)
	 •	 VLBW	 infants	 born	 in	 the	 ROI	 have	 
 significantly lower rates of retinopathy of 
 prematurity. SMR for ROP: 0.51 (95% CI: 
 0.33, 0.70).
	 •	 VLBW	 infants	 born	 in	 the	 ROI	 have	 
 significantly lower rates of cystic 
 periventricular leukomalacia (PVL). SMR 
 for PVL:  0.24 (95% CI: -0.31, 0.79).
9.  Access to the raw anonymised data will allow 
a more in-depth analysis of this important 
national dataset year on year. Important 
questions that can now be addressed include 
but are not limited to an assessment of the 
best configuration of neonatal services in 
Ireland based on neonatal transfer data 
and outcomes of VLBW infants according to 
place of birth.
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1. Background
The Vermont Oxford Network (VON) is a non-
profit voluntary collaboration of health care 
professionals dedicated to improving the 
quality and safety of medical care for newborn 
infants and their families. Established in 1988, 
the Network is today comprised of nearly 
1000 Neonatal Intensive Care Units around 
the world (Figure 1.1).
The Network maintains a database of 
information regarding the care and outcomes 
of high-risk newborn infants. The database 
provides unique, reliable and confidential 
data to participating units for use in quality 
management, process improvement, internal 
audit and peer review.
In the ROI, nine tertiary and regional neonatal 
centres joined VON in 2003, followed by the 
remaining 10 centres in 2013. This was on 
foot of a joint initiative between the NICORE 
group and the NPEC.  In 2014, all 19 neonatal 
centres in the ROI submitted data to VON, 
signifying the first year for which a National 
dataset is available. 
Figure 1.1: Member countries of the Vermont Oxford Network
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Governance
For the ROI, data submitted to VON are 
controlled by NICORE (Neonatal Intensive 
Care Outcomes Research and Evaluation) 
ROI, a group of consultant neonatologists and 
paediatricians with formal representation 
from all 19 tertiary, regional and peripheral 
neonatal centres in the Republic.  NICORE ROI 
is formally affiliated through a Memorandum 
of Understanding to the Faculty of Paediatrics, 
Royal College of Physicians of Ireland (RCPI). 
NICORE ROI is also formally affiliated to and 
functions in partnership with the National 
Perinatal Epidemiology Centre (NPEC) for the 
promotion and management of VON in the ROI. 
NICORE ROI, incorporating all neonatal centres 
in the Republic, collaborates with the five 
neonatal centres in Northern Ireland (NI). 
This cross-border collaboration has been in 
existence since 2003 when only nine centres 
in the ROI were contributing data to VON. The 
collaborative group at that time was identified 
as NICORE Ireland. When all 19 centres in 
the ROI began submitting data to VON, the 
NICORE ROI group was created.  Effectively, 
NICORE ROI is a subgroup of the parent group, 
NICORE Ireland. Figure 1.2 illustrates all units 
participating in VON in the island of Ireland.
NPEC Neonatal Care 2014 130416.indd   9 13/04/2016   17:14
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Figure 1.2: Neonatal centres in the Republic of Ireland and Northern Ireland participating in the Vermont Oxford Network. 
ROI centres are classified according to average annual number of births (in the associated obstetric centres).
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Data recording
In 2014, 19 neonatal centres participated in 
the Vermont Oxford Network (VON)’s Very Low 
Birth Weight (VLBW) database.  The definition 
of eligibility for the VLBW database is:
Anonymised data on VLBW infants born 
between 1st January and 31st December 
2014 were submitted to VON’s on-line 
database or alternatively by paper format to 
the NPEC (see Appendix C for data collection 
forms).  Figure 2.1 illustrates the flow of 
information involved. 
On completion of all ROI submissions for 2014, 
VON forwarded a copy of the complete ROI 
dataset to the NPEC.  The data presented in 
this report are based on both the ROI dataset 
and data from “Nightingale”, VON’s on-line data 
reporting system.  Throughout the report, ROI 
data is compared to VON data, comprising data 
from all centres across the Network.
 
Definitions and terminology
Birth weight: Weight from the Labour and 
Delivery record. If this is unavailable, weight 
on admission to the neonatal unit or lastly, 
the weight obtained on autopsy (if the infant 
expired within 24 hours of birth).
Gestational age: The best estimate of 
gestational age in weeks and days using the 
following hierarchy: 
•	 obstetric	 measures	 based	 on	 last	 
 menstrual period, obstetrical 
 parameters, and prenatal ultrasound as 
 recorded in the maternal chart.
•	 neonatologist’s	 estimate	 based	 on	 
 physical criteria, neurologic 
 examination, combined physical 
 and gestational ages exam (Ballard or 
 Dubowitz), or examination of the lens.
Inborn: Infant delivered at your hospital.
2. Methods

































Any infant who is born alive at your 
hospital and whose birth weight is 
between 401 and 1500 grams OR 
whose gestational age is between 
22 weeks 0 days and 29 weeks 
6 days (inclusive), regardless of 
where in your hospital the infant 
receives care
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Outborn: Infant delivered outside your 
hospital. Any infant requiring ambulance 
transfer is considered outborn.
Died in the delivery room: Death of a live born 
baby who was never admitted to the NICU, 
and died in the delivery room or at any other 
location in your hospital within 12 hours after 
birth.
Mortality: Indicates whether the infant died.
Mortality excluding early deaths: Death 
excluding those who died in the Delivery Room 
or within 12 hours of admission to the NICU.
Death or morbidity: Indicates if an infant died 
or was known to have one or more of the 
following key morbidities: severe IVH, CLD in 
infants <33 wks, NEC, pneumothorax, any late 
infection or PVL. 
Chronic Lung Disease (CLD): Based on an 
algorithm that was tested with hospital 
data and is more accurate than just oxygen 
dependency at 36 wks gestational age.  CLD 
is coded ‘yes’ if the infant is in your centre 
at 36 weeks postmenstrual age and ‘oxygen 
at 36 weeks’ is answered ‘yes’. Infants are 
considered to ‘be in your centre at 36 weeks’ 
if they have not been discharged home on 
that date or if they have been transferred from 
your centre to another centre prior to the date 
of week 36 but have been readmitted to your 
centre before discharge home, death or first 
birthday or are not transferred a second time 
before 36 weeks. 
If the infant is discharged home on or after 
34 weeks postmenstrual age but before 
36 weeks, then CLD is equal to the ‘value of 
oxygen at discharge’. The latter is recorded as 
‘yes’ for infants who went home and were on 
oxygen at the time of discharge.  If the infant 
was transferred to another hospital on or 
after 34 weeks postmenstrual age but before 
the date of week 36, then CLD is equal to the 
‘value of oxygen at the time of discharge’ from 
your institution. Again, the latter is recorded 
as ‘yes’ for infants who were transferred and 
were on oxygen at the time of discharge from 
your centre.  
If the infant is discharged home before 34 
weeks postmenstrual and is not on oxygen 
at the time of discharge, then CLD is coded 
as ‘no’. If the infant is transferred before 34 
weeks postmenstrual age and the infant is not 
on oxygen at discharge, then CLD is coded as 
‘no’. However, if the infant is discharged home 
or transferred to another hospital before 34 
weeks postmenstrual age, and the infant is 
on oxygen at the time of discharge from our 
centre, then CLD is coded as ‘unknown’.
Chronic Lung Disease (CLD) < 33 weeks 
gestation: Same algorithm applied as 
above but only includes infants < 33 weeks 
gestation.  
Pneumothorax: Extra-pleural air diagnosed 
by chest radiograph or needle aspiration 
(thoracentesis).
Late Bacterial Infection: Bacterial pathogen 
recovered from blood and/or cerebrospinal 
fluid culture obtained after day 3 of life. 
Coagulase Negative Infection: Coagulase 
negative staphylococcus recovered from a 
blood culture obtained from either a central 
line or a peripheral blood sample, and/or 
recovered from cerebrospinal fluid obtained 
by lumbar puncture, ventricular tap or 
ventricular drain after day 3 of life AND one 
or more signs of generalized infection AND 
treatment with 5 or more days of intravenous 
antibiotics. 
Nosocomial Infection: Indicates whether the 
infant has either late bacterial infection and/or 
coagulase negative staphylococcal infection 
diagnosed after day 3 of life. 
Fungal Infection: Fungus recovered from a 
blood culture obtained from either a central 
line or a peripheral blood sample after day 3 
of life.
Any Late Infection: Indicates whether the 
infant has either any late bacterial infection, 
coagulase negative infection and/or fungal 
infection after day 3 of life.
NPEC Neonatal Care 2014 130416.indd   12 13/04/2016   17:14
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Any Intraventricular Haemorrhage (IVH): 
Indicates whether the infant has a grade 
1, 2, 3 or 4 periventricular-intraventricular 
hemorrhage (PIH) on or before day 28.
Severe Intraventricular Haemorrhage (IVH): 
Indicates whether the infant has a grade 3 or 
4 periventricular-intraventricular hemorrhage 
(PIH) on or before day 28.
Retinopathy of Prematurity (ROP): Indicates 
whether the infant has stage 1, 2, 3, 4 or 5 
ROP.
Severe Retinopathy of Prematurity (ROP): 
Indicates whether the infant has stage 3, 4 or 
5 ROP. 
Cystic Periventricular Leukomalacia (PVL): 
Evidence of cystic periventricular leukomalacia 
on a cranial ultrasound, CT, or MRI scan 
obtained at any time prior to discharge.
Necrotising Enterocolitis (NEC): NEC diagnosed 
at surgery, at post-mortem examination 
or “clinically and radiographically”. To be 
diagnosed “clinically and radiographically”, 
there has to be at least one of the following 
clinical signs present: bilious gastric aspirate 
or emesis; abdominal distension; occult or 
gross blood in stool AND at least one of the 
following radiographic findings present: 
pneumatosis intestinalis, hepato-biliary air, 
pneumoperitoneum.
Extreme Length of Stay (survivors only): 
Indicates whether the infant’s total hospital 
stay is greater than the 90th percentile for the 
predicted value, based on a multivariable risk 
adjustment model.
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3. Main findings
A total of 608 VLBW infants were reported to VON 
in 2014, constituting all 19 Neonatal Intensive 
Care Units (NICUs) in the Republic of Ireland. 
Data for two of these infants was not officially 
signed off by the submitting unit, but is however 
available on Nightingale, VON’s data reporting 
system, with the result that these data are 
available for only some of the analyses to follow. 
In the case of a third infant’s data, the birth weight 
variable had been omitted, therefore excluding 
this infant from all birth weight analyses.  
Table 3.1 outlines the gestational age of infants 
reported in 2014:  41 infants were born <24 
weeks gestation, 117 were between 24 and 
26 weeks gestation, 240 between 27 and 29 
weeks gestation, 161 between 30 and 32 weeks 
gestation, and 49 infants were >32 weeks 
gestation. With regards to birth weight, 26 infants 
weighed ≤501g, two of whom were ≤401g but 
≥22 weeks gestation. A total of 86 infants had a 
birth weight in the 501-750g category, 116 in the 
751-1000g category and 155 in the 1001-1250g 
category. Overall, 224 infants weighed more than 
1250g, 16 of whom were ≥1500g but were ≤29 
weeks gestation (Table 3.2).
A total of 60,909 VLBW infants were reported to 
the Network as a whole in 2014.
Overview
Gestational age All cases No. of cases excluding 
  congenital anomalies
< 24 weeks 41 40
24-26 weeks 117 108
27-29 weeks 240 220
30-32 weeks 161 142
> 32 weeks 49 42
Total 608 552
Birth weight (g) All cases No. of cases excluding 
  congenital anomalies
< 501 26 25
501 – 750 86 82
751 – 1000 116 101
1001 – 1250 155 140
> 1250 224 203
Total 607 551
Table 3.1: Number of cases reported to VON in 2014, according to gestational age
Table 3.2: Number of cases reported to VON in 2014, according to birth weight 
One infant is excluded, as birth weight was unavailable
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Table 3.3 summarises the characteristics of 
ROI infants and compares them to those of all 
infants reported to VON in 2014.  The majority 
of infants in both the ROI and VON received 
prenatal care, were administered antenatal 
steroids and were delivered by caesarean 
section. The proportion delivered by C-Section, 
administered antenatal magnesium sulphate 
and which were small for gestational age 
(SGA) was the same amongst ROI infants 
as amongst VON infants. There were 
marginal differences that reached statistical 
significance: a higher proportion of ROI infants 
were male, were exposed to chorioamnionitis 
and were in a multiple gestation, while 
maternal hypertension was less prevalent in 
the ROI cases. Prenatal care had been provided 
for virtually all ROI cases compared to 95% of 
the VON population; antenatal steroids were 
more often administered in ROI cases; and 
congenital malformation in ROI infants was 
more than twice as common; differences that 
were highly statistically significant.
Infant Characteristics
Table 3.3: Infant characteristics in the Republic of Ireland and VON, 2014
 Characteristic   Republic of Ireland VON 
 Cases N %     N % P-value
Male 335 607  55      60,522 51 0.040
Prenatal Care 590 598  99      60,244 95 <0.001
Chorioamnionitis 96 591 16      59,511 13 0.020
Maternal Hypertension 152 599 25      60,066 30 0.014
Antenatal Steroids 516 596 87      60,127 80 <0.001
C-Section 418 605 70      60,508 71 0.303
Antenatal Magnesium Sulphate 304 593 51      58,890 52 0.720
Multiple Gestation 199 606 33      60,533 28 0.008
Congenital Malformation 54 605 9      60,490 5 <0.001
Small for Gestational Age (SGA) 152 607 25      60,409 24 0.551
Note: N represents all babies for whom the variable applies (the denominator).
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In all, 82% (n=492) of VLBW infants born 
in the ROI survived compared to 86% 
(n=51,531) of VON infants, a difference which 
was statistically significant (Table 3.4). The 
denominator for the survival variable is all 
infants who survived to discharge home or 
first birthday (n=600).  Eight infants did not 
have a valid value for this variable: these are 
all infants whose care was transferred to 
another hospital and who subsequently did 
not have their final disposition updated in the 
VON database.
The percentages of those who survived 
without specified morbidities, i.e. the key 
morbidities of severe IVH, chronic lung 
disease in infants < 33 weeks gestation, NEC, 
pneumothorax, any late infection or cystic 
PVL was 53% (n=318) in the ROI and 57% 
(n=33,983) in VON, a finding which was not 
statistically significant.  
Survival to discharge by gestational age and 
birth weight is reported in Tables 3.5 and 3.6 
respectively.  
Survival
Table 3.4: Survival of ROI and Network infants reported to VON, including those with congenital anomalies, 2014.
 Measure    Republic of Ireland   Network 
  Cases N %   Cases   N % P-value
Survival* 492 600 82% 51,531 60,200 86% 0.01
Survival without specified morbidities** 318 600 53% 33,983 60,148 57% 0.08
* Indicates whether the infant survived to discharge home or first birthday
**Denotes severe IVH, chronic lung disease in infants < 33 weeks gestation, NEC, pneumothorax, any late infection or cystic PVL.
Table 3.5: Gestational age breakdown and survival to discharge of ROI infants reported to VON, 
including those with congenital anomalies, 2014
Gestational Number of Survivors Total Number of Percentage
Age to Discharge Liveborn Infants
< 22 weeks 0 2 0%
22 weeks 0 18 0%
23 weeks 4 21 19%
24 weeks 16 34 47%
25 weeks 26 36 72%
26 weeks 28 43 65%
27 weeks 53 56 95%
28 weeks 75 83 90%
29 weeks 93 99 94%
30 weeks 69 72 96%
31 weeks 45 50 90%
32 weeks 36 38 95%
>32 weeks 47 49 96%
Total 492  601 82%
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VON reports on a number of Key Performance 
Indicators (KPIs).  This allows the ROI to 
compare its outcomes to VON as a whole. It 
is important for benchmarking performance 
in the ROI in addition to identifying areas 
of strengths and areas where continuous 
improvements could/should be made.  
The KPIs are listed below and relevant 
definitions are outlined above in the 
Definitions and Terminology section:
1. Mortality
2. Mortality Excluding Early Deaths 
3. Death or Morbidity 
4. CLD
5. CLD <33 weeks gestation
6. Pneumothorax
7. Late Bacterial Infection
8. Coagulase Negative Infection
9. Nosocomial Infection
10. Fungal Infection







18. Extreme Length of Stay (survivors only)
For each KPI, the number and percentage of 
ROI infants that experienced the outcome 
in 2014 is reported and illustrated in the 
following charts alongside the equivalent 
figures for all infants recorded in the VON 
database. The reporting of the KPIs in 
numbers and percentages for ROI and VON 
infants is provided for descriptive purposes. 
Observed differences in KPIs may be related 
to the medical care provided but may also 
be due to differences between the ROI and 
VON infant populations. Robust comparison 
of KPIs between the ROI and VON requires 
that pertinent differences between the infant 
populations are taken into account. This is 
done through the calculation of standardised 
mortality/morbidity ratios (SMRs).
Key Performance Indicators
Table 3.6: Birth weight and survival to discharge of ROI infants reported to VON, including those 
with congenital anomalies, 2014 (N=600).
Birth Weight Number of Survivors Total Number of Percentage
  to Discharge Liveborn Infants
<501g 2 26 8%
501-600g 8 31 26%
601-700g 24 36 67%
701-800g 25 35 71%
801-900g 29 37 78%
901-1000g 51 58 88%
1001-1100g 46 53 87%
1101-1200g 59 63 94%
1201-1300g 82 86 95%
1301-1400g 69 73 94%
>1400g 97 102 95%
Total 492 600 82%
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Based on all VON data for infants with birth 
weights 501-1500g, our VON colleagues use 
multivariable logistic regression models for 
each KPI to quantify the risk of the outcome 
associated with each of the following infant 
characteristics: gestational age, SGA, multiple 
gestation, Apgar score at 1 min, gender, 
vaginal birth, location (inborn or outborn) and 
birth defect severity. Coefficients from these 
regression models were provided to the NPEC 
for use in the calculation of SMRs for each KPI.
SMRs were calculated for ROI babies with 
birth weights 501-1500g and with complete 
data for the KPI in question and the infant 
characteristics used in the regression models.
For each KPI, the coefficients were applied 
to the data of these eligible ROI infants to 
estimate the risk of the outcome for each 
infant. Summing these individual risk 
estimates gives the total number of infants 
that would be expected to experience the 
outcome, i.e. the expected number taking into 
account the risk profile of the ROI infants.
To obtain the SMR for each KPI, the number of 
eligible ROI infants that actually experienced 
the outcome, i.e. the observed number of 
cases, was divided by the expected number 
of cases (SMR = Observed/Expected).
SMR values equal or close to one indicate that 
there is little or no difference between the 
observed and expected number of infants 
that experienced the outcome, i.e. the number 
observed was to be expected given the risk 
profile of the ROI infant population. SMRs 
greater than one indicate that more infants 
experienced the outcome than expected 
given the risk profile of the ROI infants. SMRs 
less than one indicate that fewer cases were 
observed among ROI infants than expected.
A 95% confidence interval was calculated 
for each SMR in order to facilitate making 
inferences about whether the SMRs reported 
indicated if the difference between observed 
and expected was statistically significant. If 
the 95% confidence interval did not include 
the value one, it may be inferred that the 
difference between the numbers of observed 
and expected cases was statistically 
significant, i.e. there were more or fewer 
cases among the ROI infants than expected 
given their risk profile.
For each KPI, the absolute difference between 
the observed and expected number of cases 
is reported and the 95% confidence interval 
for this difference is also reported in order 
to provide statements in terms of the actual 
number of infants affected.
Table 3.7 displays Standardised Mortality/
Morbidity Ratios (SMR = Observed/Expected), 
the lower and upper bounds of its 95% 
confidence interval, the difference between 
the Observed and Expected number of cases 
and the lower and upper bound of the 95% 
confidence interval for this difference.
Standard Mortality/Morbidity Ratios (SMRs)
NPEC Neonatal Care 2014 130416.indd   18 13/04/2016   17:14
 19
Table 3.7: Risk Adjusted Standardised Mortality/Morbidity Ratios for Key Performance Indicators,  
Republic of Ireland, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Mortality 86 68 1.27 (1.03, 1.51) 18 (2, 35)
Mortality excluding early death 50 41 1.23 (0.92, 1.54) 9 (-3, 22)
Death or Morbidity 260 228 1.14 (1.01, 1.27) 32 (3, 62)
Chronic Lung Disease* 104 96 1.08 (0.88, 1.28) 8 (-12, 27)
Pneumothorax 35 21 1.67 (1.25, 2.10) 14 (5, 23)
Late Bacterial Infection 34 49 0.69 (0.41, 0.97) -15 (-29, -1)
Coagulase Negative Infection 46 25 1.84 (1.45, 2.23) 21 (11, 31)
Nosocomial Infection 71 55 1.30 (1.04, 1.57) 16 (2, 31)
Fungal Infection 2 4 0.55 (-0.48, 1.57) -2 (-5, 2)
Any Late Infection 71 56 1.26 (1.00, 1.52) 15 (0, 29)
Intraventricular Haemorrhage 113 106 1.07 (0.88, 1.26) 7 (-13, 27)
Severe Intraventricular Haemorrhage 35 29 1.22 (0.85, 1.58) 6 (-4, 17)
Retinopathy of Prematurity 57 112 0.51 (0.33, 0.70) -55 (-75, -34)
Severe Retinopathy of Prematurity 15 18 0.83 (0.37, 1.29) -3 (-11, 5)
Cystic Periventricular Leukomalacia 3 13 0.24 (-0.31, 0.79) -10 (-17, -3)
Necrotising Enterocolitis 33 27 1.21 (0.84, 1.59) 6 (-4, 16)
O is the number of observed cases with the outcome and E is the expected number with the outcome of ROI infants with birth weights 501-1500g. 95% 
confidence intervals (CIs) are provided for the SMR and the difference in observed and expected cases.
*The SMR for chronic lung disease (CLD) is provided: the SMR for CLD < 33 weeks is not provided.
In 2014, 18% of VLBW babies in the ROI 
infants died (n=109). This compares to 14% 
for all infants recorded in the VON database 
(n=8,649).  Half of the ROI infants who died 
did so within the first 12 hours of life. After 
excluding such early deaths, the percentage 
who died was 9% for ROI infants (n=50) and 
10% (n=5,653) for VON infants (Figure 3.1).
There were 86 deaths observed amongst ROI 
infants with birth weights 501-1500g whereas 
the expected number based on the risk profile 
of the infants in the Irish population was 68 
(Table 3.8). The SMR was 1.27 (95% CI: 1.03, 
1.51), indicating that the number of observed 
cases was 1.27 times the expected number. 
In absolute numbers there were 18 more 
deaths than expected. This was a statistically 
significant excess in mortality (95% CI: 2, 35).
Excluding early deaths, there were 50 
observed deaths compared to an expected 
number of 41 (Table 3.8). Thus, the observed 
number equated to 1.23 times the expected 
number (SMR=1.23, 95% CI: 0.92, 1.54). In 
absolute numbers there were nine more 
cases of mortality excluding early death 
than expected but this difference was not 
statistically significant (95% CI:-3, 22).
A higher proportion of ROI infants died in the 
delivery room (8%, n=50) compared to VON 
(4%, n=2,193) (p<0.001).  Seven of the 50 
(14%) ROI infants who died in the delivery 
room had a major congenital malformation 
and a further 36 were born at less than 24 
weeks gestation.  In total, 43 of 50 infants 
who died in the delivery room in the ROI either 
had a major congenital malformation or were 
less than 24 weeks gestation.
Overall, there were 41 infants born less than 
24 weeks gestation in the ROI, the majority of 
whom died in the delivery room (n=36, 88%). 
KPI 1: Mortality and KPI 2: Mortality Excluding Early Death
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Figure 3.1: Distribution of mortality amongst ROI and VON infants, 2014. 
 
Table 3.8: Risk Adjusted Standardised Mortality Ratios for Key Performance Indicators - KPI 1: mortality and KPI 
2: mortality excluding early death, ROI, 2014  
Outcome O E SMR (95% CI) O-E (95% CI) 
Mortality 86 68 1.27 (1.03, 1.51) 18 (2, 35) 
Mortality excluding 
early death 
50 41 1.23 (0.92, 1.54) 9 (-3, 22) 
O=observed, E=expected, SMR=standardised mortality ratio, CI=confidence interval 
 
KPI 3: Death or Morbidity 
In 2014, 47% of ROI infants (n=283) suffered death or morbidity. This compares to 44% of 
VON infants (n=26,224).   
Figures 3.2 and 3.3 illustrate the change in the number of cases of death or morbidity across 
gestational age and birth weight categories respectively. As gestational age increases there 
was a clear statistically significant decrease in death or morbidity in ROI infants (p<0.001). 
Additionally, as birth weight increases there was a clear statistically significant decrease in 
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This compares to 39% (1,592 of 4,051) of 
infants born less than 24 weeks gestation in 
the VON population. Again, this difference was 
statistically significant (p<0.001).
This is an area that NICORE ROI plans to 
explore in further detail for 2014 and future 
years. It will be possible to interrogate the raw 
data to determine whether these infants are 
being delivered in local, regional or tertiary 
maternity centres, whether they are being 
offered intensive care in the delivery room 
and whether intensive care when offered in 
the delivery room is successful or not. We 
may also be able to determine if there are 
specific factors that influence the decision as 
to whether intensive care is provided in the 
delivery room or not.
Figure 3.1: Di ibution of mortality amongst R I a d VON infants, 2014.
Table 3.8: Risk Adjusted Standardised Mortality Ratios for Key Performance Indicators -  
KPI 1: mortality and KPI 2: mortality excluding early death, ROI, 2014 
Outcome O E SMR (95% CI) O-E (95% CI) 
Mortality 86 68 1.27 (1.03, 1.51) 18 (2, 35)
Mortality excluding early death 50 41 1.23 (0.92, 1.54) 9 (-3, 22) 
O=observed, E=expected, SMR=standardised mortality ratio, CI=confidence interval
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In 2014, 47% of ROI infants (n=283) suffered 
death or morbidity. This compares to 44% of 
VON infants (n=26,224).  
Figures 3.2 and 3.3 illustrate the change in the 
number of cases of death or morbidity across 
gestational age and birth weight categories 
respectively. As gestational age increases 
there was a clear statistically significant 
decrease in death or morbidity in ROI infants 
(p<0.001). Additionally, as birth weight 
increases there was a clear statistically 
significant decrease in death or morbidity in 
ROI infants (p<0.001). 
There were 260 observed cases of death or 
morbidity amongst ROI infants with birth 
weights 501-1500g whereas the expected 
number based on the risk profile of the infants 
in the Irish population was 228 cases (Table 
3.9). The SMR was 1.14 (95% CI: 1.01, 1.27), 
indicating that the number of observed cases 
was 1.14 times the expected number. In 
absolute numbers there were 32 more cases 
of death or morbidity in the ROI than expected. 
This was a statistically significant excess in 
death or morbidity (95% CI: 3, 62).





There were 260 observed cases of death or morbidity amongst ROI infants with birth weights 
501-1500g whereas the expected number based on the risk profile of the infants in the Irish 
population was 228 cases (Table 3.9). The SMR was 1.14 (95% CI: 1.01, 1.27), indicating that 
the number of observed cases was 1.14 times the expected number. In absolute numbers 
there were 32 more cases of death or morbidity in the ROI than expected. This was a 
statistically significant excess in death or morbidity (95% CI: 3, 62). 
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Figure 3.2: Distribution of death or morbidity amongst infants by gestational age, 2014
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Figure 3.3: Distribution of death or morbidity amongst infants by birth weight, 2014 
 
Table 3.9: Risk Adjusted Standardised Mortality Ratios for Key Performance Indicators - KPI 3: death or 
morbidity, ROI, 2014  
Outcome O E SMR (95% CI) O-E (95% CI) 
Death or Morbidity 260 228 1.14 (1.01, 1.27) 32 (3, 62) 
O=observed, E=expected, SMR=standardised mortality ratio, CI=confidence interval 
 
KPI 4: CLD and KPI 5: CLD < 33 weeks 
In 2014, 22% of ROI infants (n=108) were classified as having CLD. This compares to 25% of 
VON infants (n=12,836). The proportion of CLD in infants <33 gestational weeks was 24% 
(n=107) in ROI infants and 27% (n=12,532) in VON infants.  
Figures 3.4 and 3.5 illustrate the change in CLD cases across all gestational age and birth 
weight categories respectively. As gestational age increases there was a significant decrease 
in CLD cases in ROI infants (p<0.001). Likewise, as birth weight increases there was a 
significant decrease in CLD cases in ROI infants (p<0.001).  
There were 104 observed cases of CLD amongst ROI infants with birth weights 501-1500g 
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Figure 3.3: Distributi  f death or morbidity amongst infants by birth weight, 2014
Table 3.9: Risk Adjusted Standardised Mortality Ratios for Key Performance Indicators - KPI 3: death or morbidity, ROI, 2014 
Outcome O E SMR (95% CI) O-E (95% CI) 
Death or Morbidity 260 228 1.14 (1.01, 1.27) 32 (3, 62) 
O=observed, E=expected, SMR=standardised mortality ratio, CI=confidence interval
In 2014, 22% of ROI infants (n=108) were 
classified as having CLD. This compares to 25% 
of VON infants (n=12,836). The proportion of 
CLD in infants <33 gestational weeks was 24% 
(n=107) in ROI infants and 27% (n=12,532) in 
VON infants. 
Figures 3.4 and 3.5 illustrate the change 
in CLD cases across all gestational age 
and birth weight categories respectively. 
As gestational age increases there was a 
significant decrease in CLD cases in ROI 
infants (p<0.001). Likewise, as birth weight 
increases there was a significant decrease in 
CLD cases in ROI infants (p<0.001). 
There were 104 observed cases of CLD 
amo gst ROI infants with birth weights 501-
1500g whereas the expected number based 
on the risk profile of the infants in the Irish 
population was 96 (Table 3.10). The SMR was 
1.08 (95% CI: 0.88, 1.28), indicating that the 
number of observed cases was 1.08 times the 
expected number. In absolute numbers there 
were eight more cases of CLD than expected 
which was not statistically significant (95% 
CI:-12, 27).
SMR data for CLD < 33 weeks are not available.
KPI 4: CLD and KPI 5: CLD < 33 weeks






was 96 (Table 3.10). The SMR was 1.08 (95% CI: 0.88, 1.28), indicating that the number of 
observed cases was 1.08 times the expected number. In absolute numbers there were eight 
more cases of CLD than expected which was not statistically significant (95% CI:-12, 27). 
SMR data for CLD < 33 weeks are not available. 
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Figure 3.5: Distribution of chronic lung disease amongst infants by birth weight, 2014  
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Figure 3. istributi n of chro ic lung disease amongst infants by gestational age, 2014
Figure 3.5: Distribution of chronic lung disease amongst infants by birth weight, 2014 
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Figure 3.5: Distribution of chronic lung disease amongst infants by birth weight, 2014  
 






















< 501g 501-750g 751-1000g 1001-1250g > 1250g




















< 24 weeks 24-26 weeks 27-29 weeks 30-32 weeks > 32 weeks





Figure 3.7: Distribution of chronic lung disease < 33 weeks amongst infants by birth weight, 2014  
 
Table 3.10: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 4: chronic lung 
disease, ROI, 2014 
Outcome O E SMR (95% CI) O-E (95% CI) 
Chronic Lung Disease 104 96 1.08 (0.88, 1.28) 8 (-12, 27) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval 
 
KPI 6: Pneumothorax  
In 2014, 6% of ROI infants (n=34) were classified as having pneumothorax. This compares to 
4% of VON infants (n=2,565).   
Figures 3.8 and 3.9 outline the proportion of pneumothorax in ROI and VON infants according 
to gestational age and birth weight categories respectively. In ROI infants, increasing 
gestational age was associated with a slight decrease in pneumothorax but this decrease was 
not statistically significant (p=0.492). Similarly, increasing birth weight was associated with a 
slight decrease in pneumothorax but this decrease was also not statistically significant 
(p=0.910). It must be noted that overall the number of pneumothorax cases seen across the 
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Figure 3.6: Distrib ti  f chronic lung di ase < 33 weeks amo gst infants by gestational age, 2014 
Figure 3.7: Distri i n of chronic lung disease < 33 weeks amongst infants by birth weight, 2014 
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In 2014, 6% of ROI infants (n=35) were 
classified as having pneumothorax. This 
compares to 4% of VON infants (n=2,565).
  
Figures 3.8 and 3.9 outline the proportion 
of pneumothorax in ROI and VON infants 
according to gestational age and birth weight 
categories respectively. In ROI infants, 
increasing gestational age was associated 
with a slight decrease in pneumothorax but 
this decrease was not statistically significant 
(p=0.492). Similarly, increasing birth weight 
was associated with a slight decrease in 
pneumothorax but this decrease was also 
not statistically significant (p=0.910). It 
must be noted that overall the number 
of pneumothorax cases seen across the 
gestational age and birth weight categories in 
ROI infants are quite small.
There were 35 observed cases of 
pneumothorax amongst ROI infants with birth 
weights 501-1500g whereas the expected 
number based on the risk profile of the infants 
in the Irish population was 21 (Table 3.11). The 
SMR was 1.67 (95% CI: 1.25, 2.1), indicating 
that the number of observed cases was 
1.67 times the expected number. This was a 
statistically significant excess of 14 cases of 
pneumothorax (95% CI: 5, 23).





There were 35 observed cases of pneumothorax amongst ROI infants with birth weights 501-
1500g whereas the expected number based on the risk profile of the infants in the Irish 
population was 21 (Table 3.11). The SMR was 1.67 (95% CI: 1.25, 2.1), indicating that the 
n ber f observed cases w s 1.67 time  the expected number. This was a statisti lly 
significant excess of 14 cases of neumothorax (95% CI: 5, 23). 
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Figure 3.  istributi n of pneumothorax amo gst infants by gestational age, 2014 
Table 3.10: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators  
- KPI 4: chronic lung disease, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Chronic Lung Disease 104 96 1.08 (0.88, 1.28) 8 (-12, 27) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
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Figure 3.9: Distribution of pneumothorax amongst infants by birth weight, 2014  
 
Table 3.11: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 6: 
pneumothorax, ROI, 2014 
Outcome O E SMR (95% CI) O-E (95% CI) 
Pneumothorax 35 21 1.67 (1.25, 2.10) 14 (5, 23) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval 
 
KPIs 7 – 11: Infections: late bacterial infection, coagulase negative infection, 
nosocomial infection, fungal infection and any late infection.  
Figure 3.10 compares the proportion of infections in ROI and VON infants. For ROI infants, 
percentages of late bacterial infection compared favourably to the VON as a whole, but ROI 
infants had higher percentages of coagulase negative infection. Due to the higher proportion 
of coagulase negative infection in ROI infants, the percentages of nosocomial infection and 
any late infection were also higher in ROI infants.  
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Figure 3.9: Distribution of pneumothorax amongst infants by birth weight, 2014 
Table 3.11: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 6: pneumothorax, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Pneumothorax 35 21 1.67 (1.25, 2.10) 14 (5, 23) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
Figure 3.10 compares the proportion of 
infections in ROI and VON infants. For ROI 
infants, percentages of late bacterial infection 
compared favourably to the VON as a whole, 
but ROI infants had higher percentages of 
coagulase negative infection. Due to the 
higher proportion of coagulase negative 
infection in ROI infants, the percentages of 
nosocomial infection and any late infection 
were also higher in ROI infants. 
KPIs 7  1: Infections: la  bacterial infection, coagulase egative 
infection, nosocomial infection, fungal infection and any late infection. 







Figure 3.10: Distribution of infections in ROI and VON infants, 2014 
 
KPI 7: Late Bacterial Infection 
The proportion of late bacterial infection in ROI infants was 6% (n=34) compared to 8% 
(n=4,685) in all VON infants. Figures 3.11 and 3.12 illustrate the prevalence of late bacterial 
infection across all gestational age and birth weight categories respectively. As gestational 
age increases there was a statistically significant decrease in cases of late bacterial infection 
in ROI infants (p<0.001). Similarly, as birth weight increases there was a statistically significant 
decrease in cases of late bacterial infection in ROI infants (p<0.001). 
Amongst ROI infant with birth weights 501-1500g, there were 34 observed cases of late 
bacterial infection compared to an expected number of 49 cases (Table 3.12). Thus, the 
observed number equated to 69% of the expected number (SMR=0.69, 95% CI: 0.41, 0.97). In 
absolute numbers there were 15 fewer cases of late bacterial infection than expected, which 
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Figure 3.10: Di tribution of infections in ROI and VON infants, 2014
The proportion of late bacterial infection in 
ROI infants was 6% (n=34) compared to 8% 
(n=4,685) in all VON infants. Figures 3.11 and 
3.12 illustrate the prevalence of late bacterial 
infection across all gestational age and birth 
weight categories respectively. As g stational 
age increases there was a statistically 
significant decrease in cases of late bacterial 
infecti n in ROI infants (p<0.001). Similarly, a  
birth weight in rea es there was a statistically 
significant decrease in cases of late bacterial 
infection in ROI infants (p<0.001).
Amongst ROI infant with birth weights 501-
1500g, there were 34 observed cases of late 
bacterial infection compared to an expected 
number of 49 cases (Table 3.12). Thus, the 
observed number equated to 69% of the 
expected number (SMR=0.69, 95% CI: 0.41, 
0.97). In absolute numbers there were 15 
fewer cases of late bacterial infection than 
expected, which was st tistically significant 
(95% CI: -29, -1).
KPI 7: Late Bacterial Infection
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Figure 3.11: Distribution of late bacterial infection amongst infants by gestational age, 2014  
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Figure 3.11: Distribution of late bacterial infection amongst infants by gestational age, 2014  
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Figure 3.11: Distri tion of late bacterial infecti n amo gst infants by estational age, 2014 
Figure 3.12: Distri ion of late bacterial infecti n amo gst infants by birth weight, 2014 
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Coagulase negative infection was observed in 
9% (n=47) of ROI infants and 5% of VON infants 
(n=3,013). Figures 3.13 and 3.14 illustrate 
the change in cases of coagulase negative 
infection across all gestational age and birth 
weight categories respectively. In ROI infants, 
increasing gestational age was associated 
with a slight decrease in cases of coagulase 
negative infection but this decrease was not 
statistically significant (p=0.064). Increasing 
birth weight was however associated with a 
statistically significant decrease in cases of 
coagulase negative infection in ROI infants 
(p=0.013).
Adjusting for the risk profile of ROI infants 
born weighing 501-1500g, there were 46 
observed cases of coagulase negative 
infection compared to an expected number 
of 25 cases (Table 3.13). Thus, the observed 
number was almost twice the expected 
number (SMR=1.84, 95% CI: 1.45, 2.23). 
In absolute numbers there were 21 more 
cases of coagulase negative infection than 
expected, which was a statistically significant 
excess (95% CI: 11, 31).





Figure 3.13: Distribution of coagulase negative infection amongst infants by gestational age, 2014 
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Figure 3.13: Distribution of coagulase negative infection amongst infants by gestational age, 2014
Table 3.12: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 7: late bacterial infection, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Late Bacterial Infection 34 49 0.69 (0.41, 0.97) -15 (-29, -1) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
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Figure 3.13: Distribution of coagulase negative infection amongst infants by gestational age, 2014 
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Figure 3.14: Distribution of coagulase negative infection amongst infants by birth weight, 2014
Table 3.13: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 8: coagulase negative infection, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Coagulase Negative Infection 46 25 1.84 (1.45, 2.23) 21 (11, 31)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
Nosocomial infection was reported in 14% 
(n=72) of the ROI infant population and 12% 
(n=6,636) of the VON population. Figures 
3.15 and 3.16 illustrate the change in cases 
of nosocomial infection across all gestational 
age and birth weight categories respectively. 
As gestational age increases there was a 
statistically significant decrease in cases of 
nosocomial infection in ROI infants (p<0.001). 
Likewise, as birth weight increases there was 
a statistically significant decrease in cases of 
nosocomial infection in ROI infants (p<0.001).
There were 71 observed cases of nosocomial 
infection amongst ROI infants with birth 
weights 501-1500g whereas the expected 
number based on the risk profile of the infants 
was 55 cases (Table 3.14). Thus, there were 
30% more cases observed than expected 
(SMR=1.30, 95% CI: 1.04, 1.57). In absolute 
numbers this equated to an excess of 16 
cases, a statistically significant difference 
(95% CI: 2, 31).
KPI 9: Nosocomial Infection






Figure 3.15: Distribution of nosocomial infection amongst infants by gestational age, 2014 
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Figure 3.15: Distribution of nosocomial infection amongst infants by gestational age, 2014 
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Figure 3.15: Distri ion of n socomial infection amo gst infants by estational age, 2014
Figure 3.16: Distribution of nosocomial infection amongst infants by birth weight, 2014
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Two (0.4%) ROI infants experienced fungal 
infection in 2014, compared to 505 (0.9%) 
infants in the Network.  Both ROI infants were 
in the 501-750g birth weight category and 
in the 24-26 week gestational age category. 
Graphs are not included. 
The two observed cases of fungal infection 
were amongst the infants born weighing 501-
1500g. Based on the risk profile of ROI infants, 
there was an expected number of four cases 
(Table 3.15). The two fewer cases of fungal 
infection than expected did not constitute a 
statistically significant reduction in fungal 
infection cases (95% CI: -5, 2).
Any late infection was reported for 14% of 
ROI infants (n=72) and 12% of VON infants 
(n=6,860). Figures 3.17 and Figure 3.18 
illustrate the change in cases of any late 
infection across all gestational age and 
birth weight categories respectively. As 
gestational age increases there was a 
statistically significant decrease in cases of 
any late infection in ROI infants (p<0.001). 
Similarly, as birth weight increases there was 
a statistically significant decrease in cases of 
any late infection in ROI infants (p<0.001).
Considering ROI infants born weighing 
501-1500g for whom risk adjustment was 
performed, there were 71 observed cases with 
any late infection compared to an expected 
number of 56 cases (Table 3.16). Thus, the 
observed number equated to 1.26 times the 
expected number (SMR=1.26, 95% CI: 1.00, 
1.52) and the excess of 15 cases just reached 
statistical significance (95% CI: 0, 29).
KPI 10: Fungal Infection
KPI 11: Any Late Infection
Table 3.15: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 10: fungal infection, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Fungal Infection 2 4 0.55 (-0.48, 1.57) -2 (-5, 2)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
Table 3.14: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 9: nosocomial infection, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Nosocomial Infection 71 55 1.30 (1.04, 1.57) 16 (2, 31)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval






Figure 3.17: Distribution of any late infection amongst infants by gestational age, 2014 
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Figure 3.17: Distribution of any late infection amongst infants by gestational age, 2014 
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Figure 3.17: Di tribution of any late infection amo gst infants by gestational age, 2014
Figure 3.18: tribution of any late Infection amongst infants by birth weight, 2014
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Overall, 23% (n=116) of ROI infants 
experienced IVH compared to 25% (n=13,040) 
of VON infants. Severe IVH was observed in 
7% (n=35) and 8% (n=4,244) of ROI and VON 
infants respectively. Figures 3.19 and 3.20 
illustrate the change in cases of IVH across 
all gestational age and birth weight categories 
respectively. As gestational age increases 
there was a statistically significant decrease 
in cases of IVH in ROI infants (p<0.001). 
Likewise, as birth weight increases there was 
a statistically significant decrease in cases of 
IVH in ROI infants (p<0.001). 
Figures 3.21 and 3.22 illustrate the change 
in cases of severe IVH across all gestational 
age and birth weight categories respectively. 
As gestational age increases there was a 
statistically significant decrease in cases 
of severe IVH in ROI infants (p<0.001). 
Similarly, as birth weight increases there was 
a statistically significant decrease in cases of 
severe IVH (p<0.001).
IVH was observed in 113 ROI infants weighing 
501-1500g at birth whereas the number 
of cases expected based on the infants’ 
risk profile was 106 (Table 3.17). Thus, the 
observed number was only marginally higher 
than expected (SMR=1.07, 95% CI: 0.88, 1.26), 
by seven cases in absolute numbers, which 
was not a statistically significant difference 
(95% CI: -13, 27).
Similarly with severe IVH, there were 35 
observed cases compared to an expected 
number of 29 cases, an excess of six cases 
which was not statistically significant (95% 
CI: -4, 17).





Figure 3.19: Distribution of any IVH amongst infants by gestational age, 2014 
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Figure 3.19: Distribution of any IVH amongst infants by gestational age, 2014
Table 3.16: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 11: any late infection, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Any Late Infection 71 56 1.26 (1.00, 1.52) 15 (0, 29)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval






Figure 3.19: Distribution of any IVH amongst infants by gestational age, 2014 
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Figure 3.20: Dist tion of any IVH amo gs  infan s by birth weight, 2014





Figure 3.21: Distribution of severe IVH amongst infants by gestational age, 2014 
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Figure 3.21: Distribution of severe IVH amongst infants by gestational age, 2014 
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Figure 3.22: Distribution of severe IVH amongst infants by birth weight, 2014
Table 3.17: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 12: intraventricular haemorrhage and KPI 13: severe intraventricular haemorrhage, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Intraventricular Haemorrhage 113 106 1.07 (0.88, 1.26) 7 (-13, 27)
Severe Intraventricular Haemorrhage 35 29 1.22 (0.85, 1.58) 6 (-4, 17)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
ROP was reported for approximately one in eight 
ROI infants (13%, n=58) whereas ROP affected 
one in three VON infants (32%, n=13,566). 
Severe ROP (stage 3 or greater) was reported 
for 3% of ROI infants (n=14) compared to 6% 
(n=2,713) of all VON infants. Figures 3.23 and 
3.24 illustrate the change in cases of ROP across 
all gestational age and birth weight categories 
respectively. As gestational age increases there 
was a statistically significant decrease in cases 
of ROP in ROI infants (p<0.001). Likewise, as 
birth weight increases there was a statistically 
significant decrease in cases of ROP in ROI 
infants (p<0.001). 
Figures 3.25 and 3.26 illustrate the change in 
cases of severe ROP across all gestational age 
and birth weight categories. As gestational age 
increases there was a statistically significant 
decrease in cases of severe ROP in ROI infants 
(p=0.001). Similarly, as birth weight increases 
there was a statistically significant decrease in 
cases of severe ROP in ROI infants (p<0.001). It 
must be noted that overall the number of cases 
of severe ROP seen across the gestational age 
and birth weight categories are quite small.
Considering ROI infants born weighing 501-1500g 
for whom risk adjustment was performed, 
there were 57 observed cases compared to an 
expected number of 112 cases (Table 3.18). 
Thus, the observed number equated to half the 
expected number (SMR=0.51, 95% CI: 0.33, 0.70). 
In absolute numbers there were 55 fewer cases 
of ROP than expected, which was a statistically 
significant reduction (95% CI: -75, -34).
KPI 1 : ROP and KPI 15: Severe ROP
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With regard to severe ROP, there were 15 
observed cases among these infants which was 
only marginally lower than the expected number 
of 18 cases (SMR=0.83, 95% CI: 0.37, 1.29). In 
absolute numbers the three fewer cases than 






Figure 3.23: Distribution of ROP amongst infants by gestational age, 2014 
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Figure 3.23: Distribution of ROP amongst infants by gestational age, 2014 
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Figure 3.23: Distribution of ROP amongst infants by gestational age, 2014
Figure 3. : Distributi n of ROP amongst infants by birth weight, 2014
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Figure 3.25: Distribution of severe ROP amongst infants by gestational age, 2014 
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Figure 3.25: Distribution of severe ROP amongst infants by gestational age, 2014 
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Figure 3.25: Distribution of severe ROP amongst infants by gestational age, 2014
Figure 6: Distribution of severe ROP amongst infants by birth weight, 2014
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Table 3.18: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 14: retinopathy of prematurity and KPI 15: severe retinopathy of prematurity, ROI, 2014
Table 3.19: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 16: cystic periventricular leukomalacia, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Retinopathy of Prematurity 57 112 0.51 (0.33, 0.70) -55 (-75, -34)
Severe Retinopathy of Prematurity 15 18 0.83 (0.37, 1.29) -3 (-11, 5)
Outcome O E SMR (95% CI) O-E (95% CI) 
Cystic Periventricular Leukomalacia 3 13 0.24 (-0.31, 0.79) -10 (-17, -3) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
Cystic PVL was reported in just 0.6% of ROI 
infants (n=3) compared to 2.8% (n=1,514) 
of VON infants. One ROI infant was in the 751-
1000g birth weight category, one in the 1001-
1250g category and another in the >1250g 
category, whilst two of the infants had a 
gestational age of 27-29 weeks and the other, 
a gestational age of 30-32 weeks.  Graphs are 
not included. 
Considering ROI infants with 501-1500g 
birth weights, there were three observed 
cases of cystic PVL whereas the number 
expected based on their risk profile was 13 
(Table 3.19). Thus, the observed number 
equated to 24% of the expected number 
(SMR=0.24, 95% CI: -0.31, 0.79). In absolute 
numbers the ten fewer cases of cystic 
PVL represented a statistically significant 
reduction (95% CI: -17, -3).
Similar proportions of NEC were observed in 
ROI and VON infants in 2014, at 6% (n=35) 
and 5% (n=3,168) respectively. Figures 
3.27 and 3.28 illustrate the change in 
cases of NEC across all gestational age 
and birth weight categories. As gestational 
age increases there was a statistically 
significant decrease in cases of NEC in 
ROI infants (p<0.001). Likewise, as birth 
weight increases there was a statistically 
significant decrease in cases of NEC in ROI 
infants (p<0.001).
KPI 16: Cystic PVL
KPI 17: Necrotising Enterocolitis (NEC)
NPEC Neonatal Care 2014 130416.indd   39 13/04/2016   17:14





Amongst the ROI infants born weighing 501-1500g there were 33 observed cases of NEC 
which was marginally higher than the expected number of 27 cases (SMR=1.21, 95% CI: 0.84, 
1.59) (Table 3.20). The excess of six cases was not statistically significant (95% CI: -4, 16). 
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Figure 3.28: Distribution of necrotising enterocolitis amongst infants by birth weight, 2014.  
 
Table 3.20: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators - KPI 17: necrotising 
enterocolitis, ROI, 2014 
Outcome O E SMR (95% CI) O-E (95% CI) 
Necrotising 
Enterocolitis 
33 27 1.21 (0.84, 1.59) 6 (-4, 16) 
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval 
 
KPI 18: Extreme Length of Stay (Survivors only) 
Similar levels of extreme LOS i.e. LOS greater than the 90th centile for the predicted value 
based on a multivariable risk adjustment model, were reported for ROI infants at 4% (n= 15) 
and for VON infants at 4% (n=2,254) in 2014.  Figures 3.29 and 3.30 outline the percentages 
of extreme LOS according to gestational age and birth weight categories respectively. 
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Figure 3.27: Di ribution of necrotising enteroc litis amongst infants by gestational age, 2014
Figure 3.28: Distribution of necrotising enterocolitis amongst infants by birth weight, 2014. 
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Table 3.20: Risk Adjusted Standardised Morbidity Ratios for Key Performance Indicators -  
KPI 17: necrotising enterocolitis, ROI, 2014
Outcome O E SMR (95% CI) O-E (95% CI) 
Necrotising Enterocolitis 33 27 1.21 (0.84, 1.59) 6 (-4, 16)
O=observed, E=expected, SMR=standardised morbidity ratio, CI=confidence interval
Similar levels of extreme LOS i.e. LOS greater 
than the 90th centile for the predicted value 
based on a multivariable risk adjustment 
model, were reported for ROI infants at 4% 
(n= 15) and for VON infants at 4% (n=2,254) 
in 2014.  Figures 3.29 and 3.30 outline the 
percentages of extreme LOS according to 
gestational age and birth weight categories 
respectively.
SMR data for extreme LOS are not available.





Figure 3.29: Distribution of extreme length of stay amongst surviving infants by gestational age, 2014. 
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Figure . 9: Distribution of extreme length f tay amo gs  surviving infants by gestational 
age, 2014.
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Figure 3.29: Distribution of extreme length of stay amongst surviving infants by gestational age, 2014. 
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Figure 3.30: Distribution of extreme length of stay amongst surviving infants by birth weight, 2014.
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Appendix A: Endorsement by the National Office of 
Clinical Audit (NOCA)
 
National Office of Clinical Audit, 2nd Flr, Ardilaun House, 111 St Stephen’s Green, Dublin 2   Tel: 4028577                       
 
  
29th February 2016 
Dr. Brendan Paul Murphy  
Consultant Neonatologist 





Very Low Birth Weight Infants in the Republic of Ireland - Annual Report 2014 
 
 
Dear Dr Murphy, 
 
On behalf of the NOCA Governance Board and our Executive Team, I wish to congratulate you, Dr 
Anne Twomey, the Neonatal Intensive Care Outcomes Research and Evaluation (NICORE) group and 
the National Perinatal Epidemiology Centre (NPEC) and all participating neonatal units for your 
combined efforts in initiating and supporting this valuable quality improvement initiative.     
 
As you are aware, NOCA’s core objective is to support the use of clinical audit to drive improvement 
for patients in Ireland.  Improvement in care and outcomes can only be achieved by information 
gathered and monitored on how we deliver services.  We certainly encourage your approach to 
follow up and provide feedback to individual hospitals on their own data.  From this first national 
report you are in a position to inform future service delivery and support the bench marking of 
clinical care with identified standards, such as those set by the National Clinical Programme in 
Neonatology and the Faculty of Paediatrics.  Over time this will allow real change through 
monitoring, education and the implementation of change to the betterment of future care for 
mothers and babies in Ireland. 
 
Please accept this letter as formal endorsement of the first Very Low Birth Weight Infants in the 






Professor Sean Tierney 
Chair 
National Office of Clinical Audit 
 
 
c.c.  Dr. Anne Twomey, National Maternity Hospital, Holles Street, Dublin 2, Ireland 
 Prof Richard Greene, National Perinatal Epidemiology Centre, CUMH, Cork
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Appendix B: NICORE Group Members, 2014
Dr Muhammad Azam, Consultant Paediatrician, Wexford General Hospital
Dr Paula Cahill, Consultant Paediatrician, Portiuncula Hospital
Dr David Corcoran, Consultant Neonatologist, Rotunda Hospital
Dr Animitra Das, Consultant Neonatologist, University Hospital Waterford
Dr Alan Finan, Consultant Paediatrician, Cavan General Hospital
Dr Emma Gordon, Consultant Neonatologist, Our Lady of Lourdes Hospital
Dr Rizwan Gul, Consultant Paediatrician, Midland Regional Hospital Portlaoise
Dr Rizwan Khan, Consultant Paediatrician, Kerry General Hospital
Dr Imelda Lambert, Consultant Paediatrician, Midland Regional Hospital, Mullingar
Dr Jan Miletin, Consultant Neonatologist, Coombe Women & Infants University Hospital
Dr Brendan Paul Murphy, Consultant Neonatologist, Cork University Maternity Hospital
Dr Donough O’Donovan, Consultant Neonatologist, University Hospital Galway
Dr Justin Roche, Consultant Paediatrician, South Tipperary General Hospital
Dr Con Sreenan, Consultant Paediatrician, Limerick Regional Maternity Hospital
Dr Gay Fox, Consultant Paediatrician, Mayo General Hospital
Dr Mathew Thomas, Consultant Paediatrician, Letterkenny General Hospital
Dr Rohininath Tummaluru, Consultant Paediatrician, Sligo General Hospital
Dr Anne Twomey, Consultant Neonatologist, National Maternity Hospital
Dr David Waldron, Consultant Paediatrician, St. Luke’s General Hospital
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Appendix C: Vermont Oxford Network Data  
Collection Forms
Rel 18.0                                              Copyright  ©2013 Vermont Oxford Network, Inc.   All Rights Reserved.   
 
VERMONT OXFORD NETWORK  















































































Page 1:          Patient Identification Worksheet  
Page 2:          Length of Stay Calculation Worksheet  
Page 3:          28 Day Form  
Pages 4 & 5:  Discharge Form (2 pages) 
Page 6:          Transfer and Readmission Form (only infants who transfer to another hospital) 
Page 7:          Supplemental Data Form (Expanded Database only) 
 
 
W1. Patient’s Name: _________________________________________  
 
W2. Mother’s Name: _________________________________________ 
 
W3. Patient’s Medical Record Number: ________________________________ 
 
W4. Date of Birth:   _____/_____/_____ 
                MM         DD      YYYY 
 
W5. Date of Admission:  _____/_____/_____     For inborn infants, the date of admission is the Date of Birth. 
         MM          DD       YYYY           For outborn infants, the date of admission is the date the infant was  
                    admitted to your hospital. 
 
 
W6. Date of Day 28:  ____/____/____    
 MM      DD     YYYY       
 
W7. Date of Week 36:  ____/____/____    
     MM      DD     YYYY     
 
W8. Date of Initial Disposition:  _____/_____/_____   
                                                                      MM           DD        YYYY        
 
W9. If Infant Transferred, Date Discharged Home, Died or First Birthday (if still hospitalized), 
         whichever is soonest:      _____/_____/_____   
                                    MM            DD       YYYY     
DO NOT SUBMIT THIS WORKSHEET 
Protected Health Care Information 
 
PATIENT IDENTIFICATION WORKSHEET 
The Patient Identification Worksheet contains personal patient identifiers and must 
NOT be submitted to the Vermont Oxford Network. The Vermont Oxford Network 
does not accept protected health care information.   
 
Network ID Number: 
 
  1 
Center Number:__________ 
Use the Calculation Charts for Date of Day 28 and Date of Week 36 
for the infant’s birth year. 
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   Rel 18.0               Copyright ©2013 Vermont Oxford Network, Inc.  All Rights Reserved. 2 
                    
LENGTH OF STAY CALCULATION WORKSHEET  
FOR INFANTS BORN IN 2014 
 
 
Protected Health Care Information. DO NOT SUBMIT this Worksheet to Vermont Oxford Network. 
Use items W5, W8 and W9 from the Patient Identification Worksheet when completing this form. 















































PLEASE DO NOT SUBMIT THIS WORKSHEET 
Protected Health Care Information 
 
Part A. Initial Length Of Stay 
    
Enter Date of Initial Discharge, Transfer or Death (W8):  ____/____/____                                          Day # 
    




Add 1:                +   1 
                          
 
L1. INITIAL LENGTH OF STAY =             Days    
 









   
Part B. Total Length Of Stay 
Only For Infants Transferred From Your Hospital to Another Hospital. 
        
 
Enter Date of Final Discharge or Death (W9):                 ____/____/____                                         Day # 
 




Add 1:              +             1 
 
L2. TOTAL LENGTH OF STAY =            Days 
 







SAMPLE CALCULATION OF INITIAL LENGTH OF STAY  
 
 
Enter Date of Initial Discharge, Transfer or Death:  02 / 26 / 2014 
 
Subtract Date of Admission:                                    01 / 13 / 2014                               ▬ 
 
 
Add 1:              +              
 
L1. INITIAL LENGTH OF STAY =                                           Days 
 
Explanation: Date of 02/26/2014 is Day Number 57.  Date of 01/13/2014 is Day Number 13.  The day numbers for each 
date are found in the 2014-2015 Day Number Chart on the Network web site, www.vtoxford.org.    
 
     5   7  Day # 
 
     1   3  Day # 
 
     4   4 
   1 
 
     4   5 
 
Network ID Number:   Center Number:________ 
For inborn infants, the date of admission is the Date of Birth. 
For outborn infants, the date of admission is the date the infant was admitted to your hospital. 
For inborn infants, the date of admission is the Date of Birth. 
For outborn infants, the date of admission is the date the infant was admitted to your hospital. 
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 Rel 18.0 © 2013 Vermont Oxford Network, Inc.  All Rights Reserved. 07/02/2013 




28 DAY FORM - For Infants Born in 2014       
Center Number: ________   Network ID Number:            Year of Birth:    ______ 
 
  1. Birth Weight:    ________ grams    
  2. Gestational Age:      a) Weeks   _______       b) Days (0-6) _______   
  3. Died in Delivery Room:   Yes   No       (If Yes, Use Delivery Room Death Form.) 
  4.   a) Location of Birth:   Inborn  Outborn 
   
        b) If Outborn, Day of Admission to Your Center (Range: 1 to 28.  Date of Birth is Day 1):  _______ 
  
        c) If Outborn, Transfer Code of Center from which Infant Transferred: __________ 
   (List available at http://www.vtoxford.org/transfers) 
  5.   Head Circumference at Birth (in cm to nearest 10th):              
  6. Maternal Ethnicity/Race  (Answer both a and b): 
     a) Ethnicity of Mother:  Hispanic     Not Hispanic   
   b) Race of Mother:  Black or African American   White        Asian       
      American Indian or Alaska Native  Native Hawaiian or Other Pacific Islander  
         Other  
  7.  Prenatal Care:    Yes   No 
  8.  Antenatal Steroids:    Yes   No    
  9.  Antenatal Magnesium Sulfate:   Yes   No    
10.  Chorioamnionitis:   Yes   No 
11.  Maternal Hypertension, Chronic or Pregnancy-Induced:            Yes  No 
12.  Mode of Delivery:   VaginaI  Cesarean Section 
13.  Sex of Infant:    Male  Female 
14.  a) Multiple Gestation:   Yes   No      b)  If Yes, Number of Infants Delivered:  _____ 
15.  APGAR Scores:                            a) 1 minute _______      b) 5 minutes _______   
16.  Initial Resuscitation:        a) Oxygen:    Yes   No        
      b) Face Mask Vent:   Yes   No 
     c) Endotracheal Tube Vent:  Yes   No        
     d) Epinephrine:   Yes   No 
     e) Cardiac Compression:   Yes   No 
f) Nasal CPAP    Yes   No 
17.  a) Temperature Measured within the First Hour after Admission to Your NICU:     
                                                               Yes       No             N/A 
       b) If Yes, Temperature Within the  First Hour after Admission to Your NICU 
(in degrees centigrade to nearest 10th):            
18.  Bacterial Sepsis on or before Day 3:                   Yes           No 
19.  Oxygen on Day 28:     Yes                       No            N/A (See Manual for N/A criteria) 
20.  Periventricular-lntraventricular Hemorrhage (PIH): 
 
       a) Cranial Imaging (US/CT/MRI) on or before Day 28:            Yes                No  
 
       b) If Yes, Worst Grade of PIH (0-4):           _______ 
 
       c) If PIH Grade 1-4, Where PIH First Occurred:           Your Hospital      Other Hospital      N/A     
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   22. Respiratory Support (at any time after leaving the delivery room/initial resuscitation area):   
      a) Oxygen after Initial Resuscitation:      Yes    No 
      b) Conventional Ventilation after Initial Resuscitation:  Yes    No 
c) High Frequency Ventilation after Initial Resuscitation:   Yes    No 
      d) High Flow Nasal Cannula after Initial Resuscitation:   Yes    No 
e) Nasal IMV or Nasal SIMV after Initial Resuscitation:   Yes    No 
  23.  a ) Nasal CPAP after Initial Resuscitation:     Yes    No 
        b) NCPAP before or without ever having received ETT Vent:      Yes    No     N/A 
  24.   a) Surfactant during Initial Resuscitation:  Yes    No 
             b) Surfactant at Any Time:      Yes    No  (Item 24.b must be Yes if Item 24.a is Yes) 
           If Yes, Age at First Dose:    c) Hours _____ d) Minutes (0-59) _____  
  25.   a) Inhaled Nitric Oxide:       Yes  No 
        b) If Yes, where given:      Your Hospital      Other Hospital      Both 
  26.   Respiratory Support at 36 Weeks (See Manual for N/A criteria): 
         a)  Oxygen at 36 Weeks:     Yes    No     N/A     
b)  Conventional Ventilation at 36 Weeks:  Yes    No     N/A 
c)  High Frequency Ventilation at 36 Weeks:  Yes    No     N/A 
d)  High Flow Nasal Cannula at 36 Weeks:  Yes    No     N/A  
e)  Nasal IMV or SIMV at 36 Weeks:   Yes    No     N/A  
f)   Nasal CPAP at 36 Weeks:           Yes    No     N/A  
  27.   a)  Steroids for CLD:             Yes   No 
        b)  If Yes, Where Given:     Your Hospital      Other Hospital      Both     
  28.  Indomethacin for Any Reason:    Yes    No  
  29.  Ibuprofen for PDA:      Yes    No        
  30.  Probiotics:      Yes    No        
  31.  Treatment of ROP with Anti-VEGF Drug:   Yes    No        
  32.  a) ROP Surgery:         Yes    No 
      b) If Yes, Where Done:      Your Hospital      Other Hospital      Both     
  33.  a) PDA Ligation:         Yes    No 
      b) If Yes, Where Done:      Your Hospital      Other Hospital      Both 
  34.  Surgery for NEC, Suspected NEC, or   Yes    No  (If Yes, a Surgery Code is Required in item 36a) 
    Bowel Perforation: 
  35.  Other Surgery:       Yes    No  (If Yes, a Surgery Code is Required in item 36a) 
 
  36a. If Yes to NEC Surgery or Other Surgery, Surgical Codes (See Appendix D):  If NEC Surgery, one or more of 
the following codes is required: S302, S303, S307, S308, S309, S333.  Indicate location of surgery for each surgery code. 
  Surgery Code 1: ____________   Your Hospital      Other Hospital      Both 
Surgery Code 2: ____________   Your Hospital      Other Hospital      Both 
Surgery Code 3: ____________   Your Hospital      Other Hospital      Both 
Surgery Code 4: ____________   Your Hospital      Other Hospital      Both 
Surgery Code 5: ____________   Your Hospital      Other Hospital      Both 
Surgery Code 6: ____________   Your Hospital      Other Hospital      Both 
Surgery Code 7: ____________   Your Hospital      Other Hospital      Both 
Surgery Code 8: ____________   Your Hospital      Other Hospital      Both 
Surgery Code 9: ____________   Your Hospital      Other Hospital      Both 
Surgery Code 10: ___________   Your Hospital      Other Hospital      Both 
 
     36b. Include description for codes S100, S200, S300, S400, S500, S600, S700, S800, S900, S1000 & S1001: 
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  37. Respiratory Distress Syndrome:    Yes     No 
 38. a) Pneumothorax:                                   Yes       No 
      b) If Yes, Where Occurred:     Your Hospital      Other Hospital      Both    
   39. Patent Ductus Arteriosus:               Yes     No 
  40. a) Necrotizing Enterocolitis:         Yes     No 
      b) If Yes, Where Occurred:     Your Hospital      Other Hospital      Both    
  41. a) Focal Intestinal Perforation:        Yes    No 
      b) If Yes, Where Occurred:     Your Hospital      Other Hospital      Both    
Sepsis and/or Meningitis, Late (after day 3 of life):  (See Manual for N/A criteria) 
 42. a) Bacterial Pathogen:               Yes     No        N/A 
       b) If Yes, Where Occurred:     Your Hospital       Other Hospital      Both 
 43. a) Coagulase Negative Staph:       Yes    No             N/A 
       b) If Yes, Where Occurred:     Your Hospital      Other Hospital      Both 
 44. a) Fungal Infection:                       Yes     No        N/A 
       b) If Yes, Where Occurred:     Your Hospital      Other Hospital      Both 
 45. Cystic Periventricular Leukomalacia:              Yes     No        N/A (see Manual for N/A criteria)  
 46. ROP:  a) Retinal Exam Done:       Yes     No 
              b) If Yes, Worst Stage of ROP (0-5):         _____ 
 47. Major Birth Defect:       Yes     No 
    If Yes, enter codes:    _____   _____   _____   _____   ____ 
       Include description for Codes 100, 504, 601, 605, 901, 902, 903, 904 & 907:  
 
  48. Enteral Feeding at Discharge: 
           None   
           Human Milk Only   
           Formula Only  
           Human milk in combination with either fortifier or formula      
 49. Oxygen and Monitor at Discharge: 
 
        a) Oxygen at Discharge:            Yes    No    
    
        b) Monitor at Discharge:           Yes    No 
 
 50. Initial Disposition (check only one): 
          Home 
 
          Died 
 
          Transferred to another Hospital    (       Complete Transfer and Readmission Form)   
 
          Still Hospitalized as of First Birthday 
 51. Weight at Initial Disposition: _________ grams 
 52. Head Circumference at Initial Disposition (in cm to the nearest10th): 
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  TRANSFER & READMISSION FORM - For Infants Born in 2014  
 
Center Number:  ________   Network ID Number:                                      Year of Birth:  _____ 
Part A.  Complete for ALL Transferred Infants 
If an infant is transferred to another hospital, complete Items 54 - 56. Post Transfer Disposition (Item 56) refers to the  
infant's disposition upon leaving the "transferred to" hospital.  
 
54. Reason for Transfer:   Growth/Discharge Planning  Medical/Diagnostic Services  
       Surgery  ECMO  Chronic Care  Other  
55. Transfer Code of Center to which Infant Transferred: __________ (List available at http://www.vtoxford.org/transfers)  
 
   56. Post Transfer Disposition (check only one): 
    Home         Skip Parts B and C. Complete Part D.  
    Transferred Again to Another Hospital (2nd Transfer) Skip Part B. Complete Parts C and D when data are available. 
       Died       Skip Parts B and C. Complete Part D. 
    Readmitted to Any Location in Your Hospital   Complete Parts B and D (and C if applicable) when data are available. 
    Still Hospitalized as of First Birthday   Skip Parts B and C. Complete Part D. 
 
 
Part B.  Complete ONLY for Readmitted Infants 
If a patient is readmitted to your center after transferring once to another hospital without having been home, answer Items 
57 - 58.  When infants are readmitted to your center, continue to update Items 18 - 20 on the 28 Day Form, and Items 22 – 
49 on the Discharge Form based on all events at both hospitals until the date of Disposition after Readmission.  If your 
hospital participates in the Expanded Database and definition criteria are met, update Items S1.B, S1.C.1, S1.C.2, S2.A.1, 
S2.A.2 and S2.C based on events that occur following transfer and readmission. 
57. Disposition after Readmission (check only one): 
    Home         Skip Part C. Complete Part D. 
    Died         Skip Part C. Complete Part D. 
    Transferred Again to Another Hospital     Complete Parts C and D when data are available.  
    Still Hospitalized as of First Birthday      Skip Part C. Complete Part D. 
   
58. Weight at Disposition after Readmission:  _________ grams 
Part C.  Complete ONLY for Infants Who Transferred More Than Once 
 
 
Answer Item 59 if an infant transferred from your center to another hospital and was then either (1) transferred again to 
another hospital, or (2) readmitted to your center and then transferred again to another hospital.  
  
59. Ultimate Disposition (check only one):  
 
    Home         Complete Part D.   
    Died         Complete Part D.  
 
    Still Hospitalized as of First Birthday      Complete Part D. 
 
  Part D. Complete for ALL Transferred Infants 
 
Complete Item 60 when the infant has been discharged Home, Died or is Still Hospitalized as of First Birthday, whichever 
comes first. 
 
60.   Total Length of Stay:  ________day(s)    (Item L2 on Length of Stay Calculation Worksheet) 
 
(Check Only One) 
6 
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SUPPLEMENTAL DATA FORM - For Infants Born in 2014 
(For Expanded Database Centers) 
 







A. 1. Duration of Assisted Ventilation:  
             None                  <4 hours               4-24 hours               > 24 hours                  N/A 
  2. If > 24 hours, Total Days of Assisted Ventilation:  _______ 
 
 B. ECMO at your Hospital:    Yes    No    N/A 
 
     C.  Hypothermic Therapy at Your Hospital: 
1.  Was Hypothermic Therapy Performed at Your Hospital:                  Yes    No 






 A. 1. Hypoxic-lschemic Encephalopathy:   Yes   No     N/A 
  2. HIE Severity (check one):              Mild   Moderate  Severe  N/A 
 
 B. 1. Meconium Aspiration:    Yes   No     
  2. Tracheal Suction for Meconium Attempted in the DR: 
         Yes   No     N/A 
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Page 1:  Patient Identification Worksheet   




W1. Patient’s Name: ________________________________________   
 
 
W2. Mother’s Name: _________________________________________ 
 
W3. Patient’s Medical Record Number: ________________________________ 
 
W4. Date of Birth:  _____/_____/_____ 
                        MM          DD            YYYY 
 
PLEASE DO NOT SUBMIT THIS WORKSHEET 
Protected Health Care Information 
 
 
DELIVERY ROOM DEATH  
PATIENT IDENTIFICATION WORKSHEET 
Use the Delivery Room Death Booklet for eligible inborn infants who die in the delivery 
room or at any other location in your hospital within 12 hours of birth and prior to 
admission to the NICU.  
 
The Delivery Room Death Patient Identification Worksheet contains personal 
patient identifiers and must NOT be submitted to the Vermont Oxford Network.  
The Vermont Oxford Network does not accept protected health care 
information.   
 
Network ID Number:  Center Number: _______ 
1 
Delivery Room Death Booklet
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DELIVERY ROOM DEATH FORM – For Infants Born in 2014   
 
Center Number:  ________   Network ID Number:                                   Year of Birth:  _______ 
  1.  Birth Weight:                                    ________ grams   
  2.  Gestational Age:   a) Weeks _____ b) Days (0-6) _____ 
  3.  Died in Delivery Room:   Yes   No  (If NO, do not use this Form) 
  4.   a) Location of Birth:   Inborn  Outborn  (If OUTBORN, do not use this Form) 
        b and c:  Not Applicable 
 
  5.  Head Circumference at Birth (in cm to the nearest 10th):                     
  6.  Maternal Ethnicity/Race:  (answer both a and b) 
 a) Ethnicity of Mother:      Hispanic    Not Hispanic   
  b) Race of Mother:           Black or African American       White       Asian       
          American Indian or Alaska Native  Native Hawaiian or Other Pacific Islander
             Other 
  7.  Prenatal Care:            Yes  No 
  8.  Antenatal Steroids:           Yes    No 
  9.  Antenatal Magnesium Sulfate:      Yes    No 
10.  Chorioamnionitis:            Yes  No  
11.  Maternal Hypertension, Chronic or Pregnancy-Induced:               Yes   No 
12.  Mode of Delivery:            Vaginal  Cesarean Section 
13.  Sex of Infant:            Male  Female 
14.  a) Multiple Gestation:           Yes  No       b) If Yes, Number of Infants Delivered:    ______ 
15.  APGAR Scores:            a) 1 minute _____         b) 5 minutes  _____  
16.  Initial Resuscitation: a) Oxygen:                Yes   No   
b) Facial Mask Vent:               Yes   No 
    c) Endotracheal Tube Vent:  Yes   No   
d) Epinephrine:   Yes     No 
    e) Cardiac Compression:  Yes   No 
     f)  Nasal CPAP:   Yes   No 
17 – 23:  Not Applicable 
24.  Surfactant Treatment: 
  a) Surfactant during Initial Resuscitation:      Yes     No  
  b) Surfactant at Any Time:      Yes     No  (Part b must be answered “Yes” if Part a is “Yes”) 
      If Yes, Age at First Dose:             c) hours ______  d) minutes (0-59) ______   
25 – 46:  Not Applicable 
47.  Major Birth Defect:       Yes      No    If Yes, enter codes      ______  ______  ______  ______  _______ 









48 – 60:  Not Applicable 
If your center participates in the Expanded Database, answer Items S2. B.1 and S2. B.2 from the 
Supplemental Data Form.  Items S1.A. to S1.C. and Items S2.A and S2.C are not applicable. 
S2. B. 1. Meconium Aspiration:                                                               Yes                     No 
      B. 2. Tracheal Suction for Meconium Attempted in the DR:           Yes                     No  N/A 
2 
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